Trio-Tech International Inc. posted improved earnings in its fiscal third quarter as the company delivered customer orders that were delayed previously.
The Van Nuys semiconductor testing service and equipment manufacturer reported Wednesday net income of $199,000 (6 cents a share) for the quarter ended March 31, compared with a net income of $157,000 (5 cents) in the same period a year earlier. Revenue increased by 6 percent to $8.5 million. No analysts follow the company.
Product sales increased by 28 percent to $4.3 million as Trio-Tech delivered orders during the quarter that had been delayed. That growth was offset by a 10 percent decrease in semiconductor testing to $4.1 million due to slack business in Asia.
“Trio-Tech is well positioned to participate as our industry continues to recover, and we are optimistic about the outlook for the future,” said Chief Executive S.W. Yong in a prepared statement.
Shares closed up 43 cents, or nearly 16 percent, to $3.19 on the New York Stock Exchange.
Interlink Electronics Inc. improved its financials in the first quarter, the company announced Wednesday.
The Westlake Village touch-sensor technology company reported net income of $274,000 (5 cents a share) for the quarter ending March 31, compared with a net loss of $130,000 (-2 cents) in the same period a year earlier. Revenue increased 32 percent to $2.3 million. No analysts follow the company.
“I am pleased with the progress Interlink continues to achieve,” Chief Executive Steven Bronson said in a prepared statement. “In addition, we continue to expand our global team in key positions which will support our future growth.”
Last month the company hired Pierre Prud’homme as the field applications manager for Europe, and in March Mark Graham joined as vice president of product development to be based in the United Kingdom.
Interlink makes touchpads and computer-mouse products for rugged environments, such as oil refineries, automobile assembly lines and machine shops. It also serves the medical-device market.
Shares closed down 50 cents, or 6.7 percent, to $7 in over-the-counter trading.